NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1811-1819

  De Aguiar Gonçalves, Bruno Alves ^a   Vasconcelos, Gisele M ^a   Thuler, Luiz Claudio Santos ^a   Andrade, Camilla ^a   Faro, Alessandra ^a   Pombo De Oliveira, Maria S ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Acute lymphoblastic leukemia; Infant leukemia; NQO1; Polymorphisms; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; MIXED LINEAGE LEUKEMIA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; AGE DISTRIBUTION; ARTICLE; ASSAY; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FUSION GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; LEUKEMOGENESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

AGE DISTRIBUTION; ALLELES; ARYLDIALKYLPHOSPHATASE; BRAZIL; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84867988721     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0060-5     Document Type: Article

References (33)

1. Belson M, Kingsley B, Holmes A (2007) Risk factors for acute leukemia in children: a review. Environ Health Perspect 115:138-145 (Pubitemid 46050296)
2. Greaves M (1999) Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 35:1941-1953 (Pubitemid 30026216)
3. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97:230-236 (Pubitemid 34019960)
4. Bolufer P, Barragan E, Collado M, Cervera J, Lopez JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471-1491 (Pubitemid 44573473)
5. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639-649 (Pubitemid 37328819)
6. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 7:581-590 (Pubitemid 26377727)
7. Alexander FE, Patheal SL, Biondi A et al (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61:2542-2546 (Pubitemid 32685836)
8. Pombo-de-Oliveira MS, Koifman S et al (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 15:2336-2341 (Pubitemid 46048287)
9. Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6:193-203 (Pubitemid 43292563)
10. Simpson J, Smith A, Ansell P, Roman E (2007) Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer 43:2396-2403 (Pubitemid 47625972)
11. Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S et al. (2011) Pregnancy, exposure to pesticides and infant leukemia in Brazil. Environ Health Perspect. doi:http://dx.doi.org/10.1289/ehp.isee2011
12. Vasiliou V, Ross D, Nebert DW (2006) Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2:329-335
13. Rothman N, Smith MT, Hayes RB et al (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-[T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57:2839-2842 (Pubitemid 27315023)
14. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
15. Cole TB, Jampsa RL, Walter BJ et al (2003) Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364 (Pubitemid 36724529)
16. Smith MT, Wang Y, Skibola CF, et al. (2002) Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 100:4590-4593 (Pubitemid 35429702)
17. Perera FP (1999) Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 107(Suppl 3):451-460 (Pubitemid 29346991)
18. Huen K, Harley K, Brooks J et al (2009) Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms. Environ Health Perspect 117:1632-1638
19. Pombo de Oliveira MS, Koifman S, Vasconcelos GM, Emerenciano M et al (2009) Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis 42:121-125
20. So CWE (2009) Leukemia Methods and Protocols. Methods in molecular biology. Humana, London, pp 538-544
21. Pena SD, Di Pietro G, Fuchshuber-Moraes M et al (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE 6(2):e17063
22. Rios DL, D'Onofrio LO, Cerqueira CC et al (2007) Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians. Clin Chem Lab Med 45:874-878 (Pubitemid 47041881)
23. da Silva Silveira V, Canalle R, Scrideli CA et al (2009) Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 33:898-901
24. Kracht T, Schrappe M, Strehl S et al (2004) NQO1 C607T polymorphism in distinct entities of pediatric hematological neoplasms. Haematologica 89:1492-1497 (Pubitemid 39643517)
25. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF (1999) A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 59:4095-4099 (Pubitemid 29393583)
26. Sirma S, Agaoglu L, Yildiz I et al (2004) NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 43:568-570 (Pubitemid 39313956)
27. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA (2008) NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 168:1221-1232
28. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG (2002) NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4:62-70 (Pubitemid 44698580)
29. Gaikwad NW, Rogan EG, Cavalieri EL (2007) Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 43:1289-1298 (Pubitemid 47429941)
30. Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K, Reynolds P (2002) Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 110: 955-960
31. Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T (2007) Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Chem Biol Interact 168:184-192 (Pubitemid 46992662)
32. Nielsen SS, Mueller BA, De Roos AJ, Viernes HMA, Farin FM, Checkoway H (2005) Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect 113:909-913 (Pubitemid 40984194)
33. Martínez C, Molina JA, Alonso-Navarro H, Jiménez- Jiménez FJ, Agúndez JA, García-Martín E (2010) Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol 19:10